ATE306491T1 - Verfahren zur herstellung von wasserfreiem azithromycin - Google Patents

Verfahren zur herstellung von wasserfreiem azithromycin

Info

Publication number
ATE306491T1
ATE306491T1 AT01958277T AT01958277T ATE306491T1 AT E306491 T1 ATE306491 T1 AT E306491T1 AT 01958277 T AT01958277 T AT 01958277T AT 01958277 T AT01958277 T AT 01958277T AT E306491 T1 ATE306491 T1 AT E306491T1
Authority
AT
Austria
Prior art keywords
producing anhydrous
anhydrous azithromycin
azithromycin
producing
antibiotics
Prior art date
Application number
AT01958277T
Other languages
English (en)
Inventor
Anjum R Khan
Shiva P Singh
Scholl
Mukarram Jaweed
Manish Purohit
Original Assignee
Wockhardt Ltd
Khan Anjum Reyaz
Singh Shiva Prasad
Jaweed Mukarram Siddiqui Moham
Manish Purohit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd, Khan Anjum Reyaz, Singh Shiva Prasad, Jaweed Mukarram Siddiqui Moham, Manish Purohit filed Critical Wockhardt Ltd
Application granted granted Critical
Publication of ATE306491T1 publication Critical patent/ATE306491T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT01958277T 2000-08-23 2001-08-23 Verfahren zur herstellung von wasserfreiem azithromycin ATE306491T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22734100P 2000-08-23 2000-08-23
PCT/IB2001/001523 WO2002015842A2 (en) 2000-08-23 2001-08-23 Process for preparation of anhydrous azithromycin

Publications (1)

Publication Number Publication Date
ATE306491T1 true ATE306491T1 (de) 2005-10-15

Family

ID=22852706

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958277T ATE306491T1 (de) 2000-08-23 2001-08-23 Verfahren zur herstellung von wasserfreiem azithromycin

Country Status (10)

Country Link
US (2) US7414114B2 (de)
EP (1) EP1313749B1 (de)
JP (1) JP2004506664A (de)
AT (1) ATE306491T1 (de)
AU (1) AU2001280000A1 (de)
CA (1) CA2419873A1 (de)
DE (1) DE60114028T2 (de)
NO (1) NO20030772L (de)
WO (1) WO2002015842A2 (de)
ZA (1) ZA200301384B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
ES2260047T3 (es) 2000-07-25 2006-11-01 Laboratorio Silanes, S.A. De C.V. Proceso de etapa unica para la preparacion de 7,16-deoxi-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihidroxi-6-etil-3,5,9,11,13,15-hexametilbiciclo(11.2.1)hexadeca-1(2)-en-ona y obtencion de una forma nueva de 9-deoxo-9a-metil-9a-homoeritromicina a.
ATE306491T1 (de) * 2000-08-23 2005-10-15 Wockhardt Ltd Verfahren zur herstellung von wasserfreiem azithromycin
US6861413B2 (en) 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
ES2310886T3 (es) 2001-05-22 2009-01-16 Pfizer Products Inc. Nueva forma cristalina de azitromicina.
JP2005522470A (ja) * 2002-04-03 2005-07-28 ハンミ ファーム. シーオー., エルティーディー. アジスロマイシンの製造方法及びそれに用いられる9−デオキソ−9a−アザ−9a−ホモエリスロマイシンAの結晶性水和物
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
US7435805B2 (en) * 2003-05-30 2008-10-14 Glaxpsmithkline Istrazivacki O-alkyl macrolide and azalide derivatives and regioselective process for their preparation
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7683162B2 (en) 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
WO2007080507A2 (en) * 2006-01-12 2007-07-19 Wockhardt Ltd Processes for the preparation of azithromycin
CN102413826A (zh) 2009-03-13 2012-04-11 达·沃尔泰拉公司 用于消除革兰氏阴性菌的组合物和方法
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
ES2645769T3 (es) 2011-01-05 2017-12-07 Hospira, Inc. Secado por pulverización de la vancomicina
US20130172271A1 (en) * 2012-01-04 2013-07-04 Cynthia Fragale Pharmaceutical Spray Drying
CN103897002A (zh) * 2012-12-31 2014-07-02 菏泽市方明制药有限公司 一种粗品硫氰酸红霉素制备红霉素a9-肟的方法
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100504A (en) 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
US3736313A (en) 1971-02-26 1973-05-29 Abbott Lab Erythromycin derivatives
US3842068A (en) 1972-06-15 1974-10-15 Abbott Lab 8-epi-erythromycins
SI7910768A8 (en) 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
DE3136679A1 (de) 1981-09-16 1983-03-24 Bayer Ag, 5090 Leverkusen Kationische triazinfarbstoffe, ihre herstellung und verwendung
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PH19293A (en) 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
US4526889A (en) 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
US4526888A (en) 1983-04-29 1985-07-02 Bristol-Myers Company Nephrotoxicity inhibitors for aminoglycoside antibiotics
US4492688A (en) 1983-11-25 1985-01-08 Pfizer Inc. Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin A and intermediates therefor
US4464527A (en) 1983-06-30 1984-08-07 Pfizer Inc. Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
US4465674A (en) 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
JPS60214796A (ja) 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシン類の製法
US4518590A (en) 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
JPS6281399A (ja) 1985-10-04 1987-04-14 Taisho Pharmaceut Co Ltd エリスロマイシン類のオキシム誘導体の製造法
JPS6287599A (ja) 1985-10-14 1987-04-22 Taisho Pharmaceut Co Ltd エリスロマイシン類のオキシム誘導体の製造法
US5110800A (en) 1986-02-18 1992-05-05 Eli Lilly And Company Derivatives of erythromycylamine
RO107257B1 (ro) 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
WO1989002271A1 (en) 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
JP2751385B2 (ja) 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンaオキシム及びその塩の製造方法
US5141926A (en) 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
US5350839A (en) 1990-10-15 1994-09-27 Taisho Pharmaceutical Co., Ltd. 2'-position modified compound of erythromycin or its derivative
US5202434A (en) 1991-04-05 1993-04-13 Merck & Co., Inc. 8a-aza-8a-homoerythromycin lactams
US5189159A (en) 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
US5215980A (en) 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5332807A (en) 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
ES2104386T3 (es) 1993-05-19 1997-10-01 Pfizer Compuesto intermedio para la acitromicina.
US5441939A (en) 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5605889A (en) 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
US5808017A (en) 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
US5723447A (en) 1996-07-02 1998-03-03 Rhone Merieux, Inc. Water miscible erythromycin solutions
US5958888A (en) 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
ES2122905B1 (es) 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
PT102006B (pt) 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
AU2001214115A1 (en) * 2000-08-01 2002-02-13 Habil F. Khorakiwala Process for the preparation of anhydrous azithromycin
ATE306491T1 (de) * 2000-08-23 2005-10-15 Wockhardt Ltd Verfahren zur herstellung von wasserfreiem azithromycin
ES2310886T3 (es) 2001-05-22 2009-01-16 Pfizer Products Inc. Nueva forma cristalina de azitromicina.
US6855813B2 (en) 2002-07-19 2005-02-15 Alembic Limited Process for the preparation of azithromycin monohydrate
US7235646B2 (en) 2004-06-28 2007-06-26 Alembic Limited Process for the preparation of azithromycin monohydrate isopropanol clathrate
US7683162B2 (en) 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate

Also Published As

Publication number Publication date
EP1313749A4 (de) 2004-01-21
CA2419873A1 (en) 2002-02-28
US20090018090A1 (en) 2009-01-15
EP1313749B1 (de) 2005-10-12
DE60114028T2 (de) 2006-07-13
US20030139583A1 (en) 2003-07-24
ZA200301384B (en) 2004-04-02
EP1313749A2 (de) 2003-05-28
US7414114B2 (en) 2008-08-19
AU2001280000A1 (en) 2002-03-04
NO20030772L (no) 2003-04-22
DE60114028D1 (de) 2006-02-23
WO2002015842A2 (en) 2002-02-28
JP2004506664A (ja) 2004-03-04
NO20030772D0 (no) 2003-02-18
WO2002015842A3 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
ATE306491T1 (de) Verfahren zur herstellung von wasserfreiem azithromycin
ATE341529T1 (de) Verfahren zur herstellung von ultrahochreinem isopropanol
ATE386736T1 (de) Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten
ATE319422T1 (de) Verfahren zur herstellung von pulverformulierungen
AT7110U3 (de) Verfahren zur herstellung von amlodipinmaleat
ATE397608T1 (de) Verfahren zur herstellung von anagrelid
ATE328885T1 (de) Verfahren zur herstellung von sulfonamid- substituierten imidazotriazinonen
DE50104778D1 (de) Verfahren zur herstellung von polyisobutenylphenolen
DE60026607D1 (de) Verfahren zur herstellung von perfluoroalkadienen
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
ATE262576T1 (de) Verfahren zur herstellung von weichmittelzusammensetzungen
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
DE60103173D1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4-methylpyridin
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
DE60131562D1 (de) Verfahren zur herstellung von benztriazolen
EP1320367A4 (de) Verfahren zur herstellung von dinapsolin
DE60134415D1 (de) Verfahren zur herstellung von wäscheweichmacherzusammensetzungen
ATE293608T1 (de) Verfahren zur herstellung von substituierten pyrimidinen
DE60105991D1 (de) Verfahren zur herstellung von 6-aminocapronamid
DE69934334D1 (de) Verfahren zur herstellung von polyolefinen
WO2002009640A3 (en) Process for the preparation of anhydrous azithromycin
DE50112792D1 (de) Verfahren zur herstellung von kondensatorstrukturen
DE60134994D1 (de) Verfahren zur herstellung von polyurethanharnstoffpulver

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties